Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in EDIT — Editas Medicine, Inc.

CIK 1595888 NEW YORK, NY
Back to EDIT Full portfolio

Position in EDIT

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$327,672
-$2,084,315 QoQ
Shares Held
132,661
-88.7% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Derivatives in EDIT

reported options exposure · as of Mar 31, 2026
CallValue
$53,105
CallShares
21,500
PutValue
$101,517
PutShares
41,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,255,284,514 across 317 Biotechnology names. EDIT ranks #192 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 1,757,672 $130,524,721
2 RPRX
Royalty Pharma plc
 2,400,382 $115,146,324
3 TGTX
Tg Therapeutics, Inc.
 2,041,669 $67,824,242
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 122,946 $54,900,305
5 HALO
Halozyme Therapeutics, Inc.
 831,707 $53,753,223
6 EXEL
Exelixis, Inc.
 1,087,030 $46,622,715
7 JAZZ
Jazz Pharmaceuticals plc
 223,615 $42,274,415
8 BNTX
BioNTech SE
 336,757 $29,930,962

All Filings in EDIT

Export CSV
49 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $53,105 21,500
2026-03-31 $101,517 41,100
2026-03-31 $327,672 132,661
2025-12-31 $71,955 35,100
2025-12-31 $2,411,987 1,176,580
2025-09-30 $121,797 35,100
2025-09-30 $1,792,584 516,595
2025-06-30 $110,440 50,200
2025-06-30 $575,229 261,468
2025-03-31 $24,824 21,400
2025-03-31 $430,116 370,791
2024-12-31 $1,363,227 1,073,408
2024-12-31 $31,877 25,100
2024-09-30 $37,851 11,100
2024-09-30 $2,945,433 863,764
2024-06-30 $1,354,933 290,136
2024-03-31 $1,223,364 164,874
2023-12-31 $1,683,979 166,237
2023-09-30 $538,082 68,985
2023-06-30 $2,215,022 269,140
2023-03-31 $828,450 114,269
2022-12-31 $950,916 107,206
2022-09-30 $1,498,787 122,450
2022-06-30 $1,525,537 128,955
2022-03-31 $3,024,180 159,000
2022-03-31 $1,142,644 60,076
2022-03-31 $2,006,610 105,500
2021-12-31 $6,069,330 228,600
2021-12-31 $2,830,230 106,600
2021-12-31 $6,251,408 235,458
2021-09-30 $17,212,520 419,000
2021-09-30 $2,863,234 69,699
2021-09-30 $20,552,324 500,300
2021-06-30 $4,834,960 85,363
2021-06-30 $16,233,024 286,600
2021-06-30 $43,414,560 766,500
2021-03-31 $12,033,000 286,500
2021-03-31 $10,454,892 248,926
2021-03-31 $12,520,200 298,100
2020-12-31 $15,851,871 226,100
2020-12-31 $9,473,403 135,122
2020-12-31 $32,411,853 462,300
2020-09-30 $1,116,787 39,800
2020-09-30 $7,396,616 263,600
2020-09-30 $1,655,540 59,000
2020-06-30 $11,426,754 386,300
2020-06-30 $1,209,822 40,900
2020-06-30 $2,635,784 89,107
2020-03-31 $464,022 23,400

Report a Problem

Category
Description
Email (optional, for follow-up)